Enovis™ Corporation, Wilmington, Delaware, has appointed Damien McDonald as chief executive officer (CEO), effective May 12, 2025. He also joined the company’s board of directors following the conclusion of its 2025 Annual Meeting of Stockholders on May 21, 2025. McDonald succeeds Matt Trerotola.
McDonald joins Enovis with over 35 years of experience in the medical device industry. Most recently, he served as CEO of LivaNova, a global business creating clinically differentiated medical devices for the head and heart to improve the lives of patients worldwide. In his 6 years there, he drove improved results in growth, profitability, and shareholder value. He also made a meaningful impact on company culture, centered on a “Patients First” mindset.
